Prognostic Indicators of Outcome in Superior Vena Cava Obstruction in Lung Cancer

Rodrigues, George; Chu, Kuo-An

doi:10.1016/j.ijrobp.2007.07.336

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a retrospective study of NSCLC patients with SVCS, T staging, extent of disease and presence of metastatic disease were not associated with poorer survival in multivariate analysis. Performance status was the most critical prognostic factor for overall survival (44). Therefore, SVCS patients having localised disease should be offered radical treatment with advanced radiation techniques if they have a good performance status (44).…”

Section: Advances In Radiation Techniquesmentioning

confidence: 99%

See 1 more Smart Citation

Should endovascular stenting be used routinely as first-line treatment for malignant superior vena cava syndrome?—a critical review in the context of recent advances in oncological treatments

Wong¹,

Chan

David

et al. 2023

Ann Palliat Med

View full text Add to dashboard Cite

Malignant superior vena cava syndrome (SVCS) is no longer considered a medical emergency in most cases because it rarely leads to life-threatening complications. However, it results in disturbing symptoms that can significantly affect patients' quality of life. Treating this condition effectively while minimising treatment-related morbidity is of increasing importance as cancer patients are living longer from advances in oncological treatments. This clinical practice review discusses the implications of these advances on the decision to consider stenting as the initial treatment for SVCS. Stenting is increasingly popular as it provides quick symptomatic relief with low rates of complications. Systemic treatments have evolved in the past two decades with the development of immunotherapy and targeted therapies that have different response patterns compared to conventional chemotherapy. Furthermore, major changes have also been seen in radiotherapy techniques that allow treatments to better conform to targets while sparing normal tissues.These advances have changed practice patterns for stent placement in SVCS patients in both the localised and metastatic settings. Prospective studies using standardised patient-reported outcome tools are needed to determine the optimal treatment sequence for SVCS patients, as current recommendations are mainly based on retrospective single-arm studies. An individualized approach with multidisciplinary input is therefore important to optimize patient outcomes before more robust evidence is available.

show abstract

Section: Advances In Radiation Techniquesmentioning

confidence: 99%

“…Performance status was the most critical prognostic factor for overall survival (44). Therefore, SVCS patients having localised disease should be offered radical treatment with advanced radiation techniques if they have a good performance status (44).…”

Section: Advances In Radiation Techniquesmentioning

confidence: 99%